Neuronascent, Inc.
Wednesday, June 05, 2024
Start-Up Stadium Session
CNS/Neurological
5B
Company Description: Neuronascent Inc. discovers and develops novel neuron regenerative therapies for neurodegenerative and rare pediatric neurological diseases. Our disease modifying clinical-stage therapies are aimed at halting Parkinson's and Alzheimer's disease.
Company Website:
http://neuronascent.com
Company HQ City
Clarksville
Company HQ State
Maryland
Company HQ Country
United States
CEO/Top Company Official
Judith Kelleher-Andersson
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())